iShares Health Innovation Active ETF (BMED) is an ETF managed by BlackRock / iShares. Its largest position is JOHNSON & JOHNSON (JNJ), representing 7.88% of fund assets.
iShares Health Innovation Active ETF Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- BMED
- Type:
- ETF
- Manager:
- BlackRock / iShares
- Total Assets:
- —
- Report Date:
- Apr 30, 2026
- Filing Date:
- Jun 25, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
JOHNSON & JOHNSON
|
7.88% | $795,051.15 | 3,459 |
|
-
GILEAD SCIENCES, INC.
|
5.40% | $544,948.60 | 4,165 |
|
-
Edwards Lifesciences Corp
|
4.74% | $478,121.00 | 5,726 |
|
-
AMGEN INC
|
4.60% | $464,667.50 | 1,342 |
|
-
BLACKROCK CASH FUNDS TREASURY SL AGENCY SHARES
|
4.36% | $440,000.00 | 440,000 |
|
-
Merck & Co., Inc.
|
3.92% | $395,231.60 | 3,620 |
|
-
BIOGEN INC.
|
3.63% | $366,256.80 | 1,935 |
|
-
WUXI BIOLOGICS (CAYMAN) INC.
|
3.22% | $324,728.69 | 76,000 |
|
-
WATERS CORP /DE/
|
3.17% | $320,053.05 | 1,035 |
|
-
METTLER TOLEDO INTERNATIONAL INC/
|
3.10% | $312,769.45 | 245 |
|
-
INTUITIVE SURGICAL INC
|
2.95% | $297,904.11 | 651 |
|
-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
|
2.95% | $297,707.51 | 1,783 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
2.92% | $294,892.20 | 690 |
|
-
ARGENX SE
|
2.85% | $287,672.96 | 368 |
|
-
Moderna, Inc.
|
2.64% | $266,635.76 | 5,804 |
|
-
PFIZER INC
|
2.48% | $250,793.10 | 9,393 |
|
-
DANAHER CORP /DE/
|
2.48% | $250,172.10 | 1,398 |
|
-
BRUKER CORP
|
2.32% | $234,540.19 | 6,389 |
|
-
NOVARTIS AG
|
2.31% | $233,359.89 | 1,579 |
|
-
BIO-TECHNE Corp
|
2.09% | $210,492.60 | 3,805 |
|
-
DEXCOM INC
|
2.06% | $208,008.15 | 3,493 |
|
-
GSK plc
|
2.03% | $205,369.06 | 3,926 |
|
-
Protagonist Therapeutics, Inc
|
1.99% | $201,008.07 | 2,031 |
|
-
THERMO FISHER SCIENTIFIC INC.
|
1.94% | $195,415.68 | 408 |
|
-
ROCHE HOLDING AG
|
1.80% | $181,744.93 | 446 |
|
-
INSMED Inc
|
1.79% | $180,773.58 | 1,326 |
|
-
ASTRAZENECA PLC
|
1.62% | $163,948.75 | 875 |
|
-
UCB SA
|
1.58% | $159,562.69 | 586 |
|
-
Cogent Biosciences, Inc.
|
1.56% | $157,225.47 | 4,393 |
|
-
INCYTE CORP
|
1.55% | $156,719.15 | 1,645 |
|
-
IDEXX LABORATORIES INC /DE
|
1.42% | $143,564.80 | 256 |
|
-
BOSTON SCIENTIFIC CORP
|
1.39% | $140,280.35 | 2,435 |
|
-
BRISTOL MYERS SQUIBB CO
|
1.30% | $131,419.71 | 2,169 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
1.22% | $122,914.80 | 2,280 |
|
-
TEVA PHARMACEUTICAL INDUSTRIES LTD
|
1.18% | $118,747.02 | 3,386 |
|
-
Revolution Medicines, Inc.
|
1.03% | $104,198.76 | 723 |
|
-
ALCON AG
|
1.01% | $101,823.20 | 1,360 |
|
-
Summit Therapeutics Inc.
|
0.75% | $75,260.22 | 3,507 |
|
-
Medline Inc.
|
0.64% | $64,881.73 | 1,459 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
0.57% | $57,157.80 | 651 |
|
-
BioNTech SE
|
0.52% | $52,449.15 | 507 |
|
-
APOGEE THERAPEUTICS INC
|
0.47% | $47,744.64 | 576 |
|
-
BLACKROCK FUNDS III
|
0.25% | $25,637.93 | 25,630 |
|
-
Sagimet Biosciences Inc.
|
0.13% | $13,554.64 | 1,688 |
|
-
Erasca, Inc.
|
0.13% | $13,323.15 | 1,251 |
|
-
Eikon Therapeutics, Inc.
|
0.12% | $12,047.60 | 1,253 |
|
-
Ultragenyx Pharmaceutical Inc.
|
0.11% | $11,357.40 | 460 |
|
-
ABIOMED INC.
|
0.00% | $371.46 | 246 |
|
-
CONTRA MIRATI THERAPEU
|
0.00% | $263.86 | 334 |
|
-
CONTRA BLUEPRINT MEDIC
|
0.00% | $110.00 | 110 |
Advertisement (320x50)